feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Science / Most Alzheimer's Cases Linked to Single Gene

Most Alzheimer's Cases Linked to Single Gene

9 Jan

•

Summary

  • A specific variant of the APOE gene is linked to most Alzheimer's cases.
  • The common APOE ε3 variant, previously thought neutral, is now implicated.
  • Targeting APOE offers potential for preventing a majority of Alzheimer's.
Most Alzheimer's Cases Linked to Single Gene

Scientists have discovered that a common gene variant, APOE ε3, plays a significant role in almost all cases of Alzheimer's disease. Previously, attention focused on the ε4 variant, but new research indicates that without the ε3 variant, most Alzheimer's cases would not develop. This finding, stemming from analysis of 450,000 participants, suggests that 72 to 93 percent of Alzheimer's cases are associated with APOE ε3 and ε4.

The APOE gene, essential for clearing amyloid-beta proteins, has three common types: ε2, ε3, and ε4. While ε4 is known to increase risk, the ε3 variant, once thought harmless, is now recognized as critical. Researchers estimate that approximately 45 percent of all dementia cases would also be preventable if the risk conferred by these APOE variants could be mitigated.

This research highlights the APOE gene as a powerful target for future Alzheimer's drug development and prevention. While not the sole cause, understanding its significant contribution offers hope for strategies that could potentially prevent a majority of the disease. Further clinical trials are needed to explore treatments specifically for individuals with higher genetic risk.

trending

BCA withdraws ICE shooting investigation

trending

McIntyre wins WWE Championship

trending

Real Sociedad late win

trending

Mark Cuban donates to Indiana

trending

Anthony Davis hand injury update

trending

Morocco beats Cameroon in AFCON

trending

Grizzlies seeking Ja Morant trade

trending

Wrexham beats Nottingham Forest

trending

Dortmund draws with Frankfurt

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
UCL researchers found that the APOE gene's ε3 and ε4 variants are linked to almost all Alzheimer's disease cases, making it a key target for drug development.
The study estimates that 72 to 93 percent of Alzheimer's cases would not occur without the APOE ε3 and ε4 variants.
Currently, routine NHS testing for APOE genotype is not available as it's unclear what actions individuals could take with that information. Further research and clinical trials are needed.

Read more news on

Scienceside-arrow

You may also like

Small Heads, Lower Education Raise Dementia Odds

2 Jan • 50 reads

article image

New Alzheimer's Blood Test: Early Detection Breakthrough

17 Dec, 2025 • 114 reads

article image

Driving Habits Hint at Alzheimer's Risk

3 Dec, 2025 • 195 reads

article image

Weight Loss Jabs Slow Alzheimer's Decline

3 Dec, 2025 • 169 reads

article image

Boost Activity, Cut Dementia Risk by 45%

28 Nov, 2025 • 224 reads

article image